Tag: FDA approval for rare disease therapy
FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides
Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic disease. This therapy targets patients suffering from familial chylomicronemia syndrome...